Prospects for Antisense Nucleic Acid Therapy of Cancer and AIDS

Por Tidd, D.M.
Publicado em 1993

Synthetic oligonucleotides as therapeutic agents.

Por Tidd, D. M.
Publicado em 1991

Increased specificity for antisense oligodeoxynucleotide targeting of RNA cleavage by RNase H using chimeric methylphosphonodiester/phosphodiester structures.

Por Giles, R V, Tidd, D M
Publicado em 1992

Partial protection of oncogene, anti-sense oligodeoxynucleotides against serum nuclease degradation using terminal methylphosphonate groups.

Por Tidd, D. M., Warenius, H. M.
Publicado em 1989

The effects of 6-mercaptopurine nucleotide derivatives on the growth and survival of 6-mercaptopurine-sensitive and -resistant cell culture lines.

Por Johnston, H. P., Hawley, P., White, S. E., Gibson, I., Tidd, D. M.
Publicado em 1985

Single base discrimination for ribonuclease H-dependent antisense effects within intact human leukaemia cells.

Por Giles, R V, Ruddell, C J, Spiller, D G, Green, J A, Tidd, D M
Publicado em 1995

Selecting optimal oligonucleotide composition for maximal antisense effect following streptolysin O-mediated delivery into human leukaemia cells.

Por Giles, R V, Spiller, D G, Grzybowski, J, Clark, R E, Nicklin, P, Tidd, D M
Publicado em 1998

Determination of optimal sites of antisense oligonucleotide cleavage within TNFα mRNA

Por Lloyd, B. H., Giles, R. V., Spiller, D. G., Grzybowski, J., Tidd, D. M., Sibson, D. R.
Publicado em 2001